Donald Engelman
Donald Max Engelman is Higgins Professor of Biochemistry at Yale University. He is a member of the National Academy of Sciences, fellow of the American Academy of Arts and Sciences, a fellow of the National Institutes of Health, and has been a Guggenheim fellow. He is a director of the Stryker Corporation. He is involved in the creation of new cancer drugs and treatments. For example, Engelman is involved in research to use peptides to aid in destroying tumors.Administration, advising, and consulting
Engelman has served as Director of Biological Sciences at Yale, an advisor to the Brookhaven National Laboratory, and a consultant to the Los Alamos National Laboratory. He also served as Acting Dean of Yale College in 1991.Education
Engelman is a graduate of Reed College and Yale University.Engelman Lab
Engelman directs the Engelman Laboratory at Yale.Patents
Engelman holds six United States patents for his discoveries.
